About Shanghai Yi Nuo Pharmaceutical
Shanghai Yi Nuo Pharmaceutical is a Healthcare company based in Shanghai (China) founded in 2016. Shanghai Yi Nuo Pharmaceutical has raised $24.23 million across 3 funding rounds from investors including ddtxcf.com, Zhang Ke and Sunland Capital. Shanghai Yi Nuo Pharmaceutical offers products and services including Immune Therapies and eSTEM Platform. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity in India is δΈζ΅·θ½Άθ―Ίθ―δΈζιε ¬εΈ (U99999MH1977PLC010754).
Company details
Manufacturer of HDPE and PVC pipes, sprinkler, and drip irrigation systems. It produces a variety of piping solutions for various applications. The companys manufacturing process utilizes state-of-the-art technology and a computerized process control system to ensure consistent product quality. A commitment to quality is evident through rigorous testing of each product and adherence to ISO:9001 standards. The company aims to provide timely deliveries and competitive pricing while prioritizing customer satisfaction. Its product line includes HDPE pipes, PVC pipes, sprinkler systems, mini sprinkler systems, drip irrigation systems, and various pipe fittings.
- Headquarters Shanghai, China
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website ennovabio.com
- Legal Name 上海轶诺药业有限公司
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Total Equity Funding$24.23M (USD)
in 3 rounds
- Investorsddtxcf.com
& 4 more
Associated legal entities of Shanghai Yi Nuo Pharmaceutical
Shanghai Yi Nuo Pharmaceutical operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Shanghai Yi Nuo Pharmaceutical
Shanghai Yi Nuo Pharmaceutical offers a comprehensive portfolio of products and services, including Immune Therapies and eSTEM Platform.
Therapies for immune and metabolic diseases are developed through research on the company's pipeline.
The eSTEM system biology platform is employed for advancing drug discovery in areas like immunology and inflammation.
Funding Insights of Shanghai Yi Nuo Pharmaceutical
Shanghai Yi Nuo Pharmaceutical has successfully raised a total of $24.23M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $24.23M
- Total Rounds 3
- First Round $10M
(Sep 2017)
- Investors Count 5
All 3 funding rounds of Shanghai Yi Nuo Pharmaceutical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | Series B | β | Zhang Ke | ||
| Nov 2019 | $14.23M | Series A | β | Matrix Partners China | |
| Sep 2017 | $10M | Seed | β | β |
5 investors in total: 4 institutional and 1 angel.
Investors in Shanghai Yi Nuo Pharmaceutical
Shanghai Yi Nuo Pharmaceutical has secured backing from 5 investors, including angel and venture fund investors. Prominent investors backing the company include ddtxcf.com, Zhang Ke and Sunland Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sunland Capital is focused on early-stage healthcare industry investments. | 2014 | sunlandfund.com | Shanghai, China | |
Multiple sectors are invested in by this venture capital firm. | matrixpartners.com.cn | Chaoyang, China | ||
Private equity and early-stage venture capital firm investing primarily in Chinese companies | highlightcapital.com | Shanghai, China | ||
ZK Zhang Ke | Indian angel investor with focus on tech startups and innovation. | unknown_487240c5a9c949419 | ||
| ddtxcf.com |
Investor details for Shanghai Yi Nuo Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Shanghai Yi Nuo Pharmaceutical
3 dated milestones of Shanghai Yi Nuo Pharmaceutical across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Shanghai Yi Nuo Pharmaceutical is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series B,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Shanghai Yi Nuo Pharmaceutical
Complete news archive for Shanghai Yi Nuo Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shanghai Yi Nuo Pharmaceutical
Shanghai Yi Nuo Pharmaceutical was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Shanghai Yi Nuo Pharmaceutical is headquartered in Shanghai, China.
Shanghai Yi Nuo Pharmaceutical is a funded company, having raised a total of $24.23M across 3 funding rounds to date. The company's 1st funding round was a Seed of $10M, raised on Sep 2017.
Manufacturer of HDPE and PVC pipes, sprinkler, and drip irrigation systems. It produces a variety of piping solutions for various applications. The companys manufacturing process utilizes state-of-the-art technology and a computerized process control system to ensure consistent product quality. A commitment to quality is evident through rigorous testing of each product and adherence to ISO:9001 standards. The company aims to provide timely deliveries and competitive pricing while prioritizing customer satisfaction. Its product line includes HDPE pipes, PVC pipes, sprinkler systems, mini sprinkler systems, drip irrigation systems, and various pipe fittings.
Shanghai Yi Nuo Pharmaceutical offers Immune Therapies and eSTEM Platform.
Shanghai Yi Nuo Pharmaceutical has 5 investors. Key investors include ddtxcf.com, Zhang Ke, Sunland Capital, Matrix Partners China, and Highlight Capital.
Shanghai Yi Nuo Pharmaceutical operates through ,.